You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 88 No. 2, February 1964 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Derivation of Fibroblasts in the Healing Wound

HERMES C. GRILLO, MD

AMA Arch Surg. 1964;88(2):218-224.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Understanding of the biochemistry of fibrogenesis in wound repair has increased steadily. Recent advances in knowledge of this process have been reviewed by Grillo,21 Harkness,24 and Jackson,31 among others. Correspondingly little increment had occurred in comprehension of the mechanisms of cellular stimulation prior to beginning of fibrogenesis or of regulation of proliferation and productivity of cells thereafter. Recently there has been renewed interest in an early phase of this problem—the question of site of origin of fibroblasts in wound repair. New contributions are reviewed against the background of the ancient and continuing controversy over histogenous against vascular derivation of fibroblasts.

Origins of Controversy

Virchow's belief in the immutable lineage of cells found expression in the assertions by Marchand 38 and Aschoff 4 on histologic grounds that fibroblasts in wound healing were derived from the connective tissues of the wound. Maximow, however, studying fixed sections of inflammatory exudate . . . [Full Text PDF of this Article]


Author Affiliations

BOSTON

Assistant Clinical Professor of Surgery.; From the John Collins Warren Laboratories of the Huntington Memorial Hospital, the Robert W. Lovett Memorial Unit for the Study of Crippling Diseases, and the Harvard Medical School Department of Surgery at the Massachusetts General Hospital.


Footnotes

Submitted for publication Sept 10, 1963.

This is publication 1139 of the Cancer Commission of Harvard University and 344 of the Robert W. Lovett Memorial Unit for the Study of Crippling Diseases, Harvard Medical School at the Massachusetts General Hospital.

Preparation of this article was aided by research grant C-3638 from the National Cancer Institute of the United States Public Health Services and A. E. C. contract AT (30-1) 2643.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1964 American Medical Association. All Rights Reserved.